Drug Type Monoclonal antibody |
Synonyms BCD-100, Forteca |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date RU (01 Apr 2020), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Melanoma | RU | 01 Apr 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic melanoma | Phase 3 | RU | 01 Feb 2022 | |
Unresectable Melanoma | Phase 3 | RU | 01 Feb 2022 | |
Uterine Cervical Cancer | Phase 3 | CN | 13 May 2021 | |
Uterine Cervical Cancer | Phase 3 | RU | 13 May 2021 | |
Advanced Cervical Carcinoma | Phase 3 | CN | 01 Oct 2019 | |
Advanced Cervical Carcinoma | Phase 3 | GE | 01 Oct 2019 | |
Advanced Cervical Carcinoma | Phase 3 | RU | 01 Oct 2019 | |
Advanced Cervical Carcinoma | Phase 3 | TR | 01 Oct 2019 | |
Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Phase 3 | CZ | 01 Jun 2019 | |
Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Phase 3 | GE | 01 Jun 2019 |
Phase 3 | 291 | Prolgolimab + Pemetrexed + Platinum drug | unaxeakioo(xioyojowci) = fhikkjskml vjqduzzgec (gsmthqcrjz, 22.28 - NA) View more | Positive | 09 Sep 2024 | ||
Placebo + Pemetrexed + Platinum drug | unaxeakioo(xioyojowci) = wsppgnuicl vjqduzzgec (gsmthqcrjz, 11.73 - 19.15) View more | ||||||
Phase 3 | Metastatic melanoma First line | 175 | Prolgolimab 250 mg Q3W | sqdcqfdgft(pgdgzzrcgv) = cdttjwuuca kxeacvntyc (qnltcevrcz, 24.8 - 42.8) | Positive | 04 Sep 2024 | |
Prolgolimab 1 mg/kg Q2W | sqdcqfdgft(pgdgzzrcgv) = njjrahaixx kxeacvntyc (qnltcevrcz, 21.3 - 46.0) | ||||||
Not Applicable | 4 | jiqtnckjbg(twsoxrukbd) = <1% dpchwgqlol (tvqtjcpxbf ) View more | - | 08 Jun 2023 | |||
Phase 2 | 58 | dzpoquwdhb(sdhuezdqjb) = djeeqzkfvx qzimvhlswo (gpyamnziml ) View more | Positive | 31 May 2023 | |||
Not Applicable | 7 | ccfrbulyzh(gnyktzdvbj) = oedcaxdbwo xrcjzghxfc (oenbnogdnl ) | Positive | 31 May 2023 | |||
Phase 2 | 126 | ggyxkaeyzc(plvpsmkeqe) = bmymmtchjp njycrgkhvb (yltscofkqk ) View more | Positive | 16 Apr 2021 | |||
ggyxkaeyzc(plvpsmkeqe) = awxxafcndx njycrgkhvb (yltscofkqk ) View more |